Evidence map›Paper›PMID 31854220›Full record

ArticlePharmaceutical biology2020

Curcumin inhibited the growth and invasion of human monocytic leukaemia SHI-1 cells

Guohua Zhu, Qun Shen, Hong Jiang, Ou Ji, Lingling Zhu, Linyang Zhang

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Cancer chemoprevention: signaling pathways and strategic approaches.Signal transduction and targeted therapy · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Guohua ZhuFirst Clinical College, Nanjing University of Chinese Medicine, Nanjing, China.
Qun ShenFirst Clinical College, Nanjing University of Chinese Medicine, Nanjing, China.
Hong JiangFirst Clinical College, Nanjing University of Chinese Medicine, Nanjing, China.
Ou JiFirst Clinical College, Nanjing University of Chinese Medicine, Nanjing, China.
Lingling ZhuFirst Clinical College, Nanjing University of Chinese Medicine, Nanjing, China.
Linyang ZhangFirst Clinical College, Nanjing University of Chinese Medicine, Nanjing, China.
Nanjing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCell Line, TumorCell ProliferationCurcuminDose-Response Relationship, DrugFemaleHumansLeukemia, Monocytic, AcuteMAP Kinase Signaling SystemMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceMice, SCIDNeoplasm InvasivenessAntineoplastic Agents, PhytogenicCurcuminMatrix Metalloproteinase 2Matrix Metalloproteinase 9NF-kappa BAcute myeloid leukaemiamatrix metalloproteinasemetastasismitogen-activated protein kinase

Identifiers

PMID31854220
PMCPMC6968541
OpenAlexW2995605794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.